[Cytostatic therapy of malignant reticuloses and retothelial sarcomatoses].
D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D014228:Triaziquone / Q000627:therapeutic use
D003520:Cyclophosphamide; D014228:Triaziquone
Beitrag zur zytostatischen Therapie der malignen Retikulosen und Retothelsarkomatosen.